References
- HolgateSTPolosaRThe mechanisms, diagnosis, and management of severe asthma in adultsLancet2006368953778079316935689
- The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthmaEuropean network for understanding mechanisms of severe asthmaEur Respir J200322347047714516137
- Van GanseELaforestLPietriGPersistent asthma: disease control, resource utilisation and direct costsEur Respir J200220226026712212953
- AntoncelliLBuccaCNeriMDe BenedettoFSaabbataniPBFAsthma severity and medical resource utilizationEur Respir J20042372372915176687
- GodardPChanezPSiraudinLNicoloyannisNDuruGCosts of asthma are correlated with severity: a 1-yr prospective studyEur Respir J2002191616711843329
- Global Initiative for Asthma Global strategy for asthma management and preventionA six part management program NIH publication number 02-36592006
- ChungKFGodardPAdelrothEDifficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory SocietyEur Respir J19991351198120810414427
- WenzelSFahyJVIrvinCGPetersSPSpectorSSzeflerSJProceedings of the ATS Workshop on Refractory Asthma: current understanding, recommendations and unanswered questionsAm J Respir Crit Care Med20001622341235111112161
- WenzelSSevere asthma in adultsAm J Respir Crit Care Med2005172214916015849323
- PolosaRBenfattoGTManaging patients with chronic severe asthma: rise to the challengeEur J Intern Med200920211412419327598
- ChanezPWenzelSEAndersonGPSevere asthma in adults: what are the important questions?J Allergy Clin Immunol200711961337134817416409
- GINA Report, Global Strategy for Asthma Management and Prevention NIH publication number 02-3659.2009
- PolosaRMorjariaJImmunomodulatory and biologic therapies for severe refractory asthmaRespir Med2008102111499151019012848
- BucknallCESlackRGodleyCCMackayTWWrightSCScottish Confidential Inquiry into Asthma Deaths (SCIAD), 1994–6Thorax1999541197898410525555
- BenderBGOvercoming barriers to nonadherence in asthma treatmentJ Allergy Clin Immunol2002109Suppl 6S554S55912063512
- WeinsteinAGShould patients with persistent severe asthma be monitored for medication adherence?Ann Allergy Asthma Immunol200594225125715765741
- CurrieGPDouglasJGHeaneyLGDifficult to treat asthma in adultsBMJ2009338b49419240094
- RobinsonDSCampbellDADurhamSRPfefferJBarnesPJChungKFSystematic assessment of difficult-to-treat asthmaEur Respir J200322347848314516138
- CochraneGMHorneRChanezPCompliance in asthmaRespir Med1999931176376910603624
- MooreWCBleeckerERCurran-EverettDCharacterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research ProgramJ Allergy Clin Immunol2007119240541317291857
- British Thoracic Society and Scottish Intercollegiate Guideline NetworkBritish guideline on the management of asthmaThorax200863Suppl 4iv1iv12118463203
- CrapoROCasaburiRCoatesALGuidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999Am J Respir Crit Care Med2000161130932910619836
- TinkelmanDGPriceDBNordykeRJHalbertRJMisdiagnosis of COPD and asthma in primary care patients 40 years of age and overJ Asthma2006431758016448970
- GreenbergerPAAllergic bronchopulmonary aspergillosis, allergic fungal sinusitis, and hypersensitivity pneumonitisClin Allergy Immunol20021644946811577554
- NothIStrekMELeffARChurg – Strauss syndromeLancet2003361935758759412598156
- GoldmanJMuersMVocal cord dysfunction and wheezingThorax19914664014041858076
- WoodRP2ndMilgromHVocal cord dysfunctionJ Allergy Clin Immunol19969834814858828523
- HeaneyLGConwayEKellyCPredictors of therapy resistant asthma: outcome of a systematic evaluation protocolThorax200358756156612832665
- ten BrinkeAGrootendorstDCSchmidtJTChronic sinusitis in severe asthma is related to sputum eosinophiliaJ Allergy Clin Immunol2002109462162611941310
- BrescianiMParadisLDes RochesARhinosinusitis in severe asthmaJ Allergy Clin Immunol20011071738011149994
- MasciaKHaselkornTDenizYMMillerDPBleeckerERBorishLAspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthmaJ Allergy Clin Immunol2005116597097516275362
- CorrenJAllergic rhinitis and asthma: how important is the link?J Allergy Clin Immunol1997992S781S7869042071
- CeylanEGencerMSanINasal polyps and the severity of asthmaRespirology200712227227617298462
- FieldSKUnderwoodMBrantRCowieRLPrevalence of gastroesophageal reflux symptoms in asthmaChest199610923163228620699
- LittnerMRLeungFWBallardED2ndHuangBSamraNKEffects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptomsChest200512831128113516162697
- KiljanderTOHardingSMFieldSKEffects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trialAm J Respir Crit Care Med2006173101091109716357331
- LeggettJJJohnstonBTMillsMGambleJHeaneyLGPrevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcomeChest200512741227123115821199
- MastronardeJGAnthonisenNRCastroMEfficacy of esomeprazole for treatment of poorly controlled asthmaN Engl J Med2009360151487149919357404
- CollinsJEGillTKChittleboroughCRMartinAJTaylorAWWinefieldHMental, emotional, and social problems among school children with asthmaJ Asthma200845648949318612902
- MilesJFGardenGMTunnicliffeWSCaytonRMAyresJGPsychological morbidity and coping skills in patients with brittle and non-brittle asthma: a case-control studyClin Exp Allergy19972710115111599383255
- Roy-ByrnePPDavidsonKWKesslerRCAnxiety disorders and comorbid medical illnessGen Hosp Psychiatry200830320822518433653
- KullowatzARosenfieldDDahmeBMagnussenHKanniessFRitzTStress effects on lung function in asthma are mediated by changes in airway inflammationPsychosom Med200870446847518480192
- LangePParnerJVestboJSchnohrPJensenGA 15-year follow-up study of ventilatory function in adults with asthmaN Engl J Med199833917119412009780339
- EisnerMDIribarrenCThe influence of cigarette smoking on adult asthma outcomesNicotine Tob Res200791535617365736
- MarquetteCHSaulnierFLeroyOLong-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthmaAm Rev Respir Dis1992146176811626819
- ChaudhuriRLivingstonEMcMahonADThomsonLBorlandWThomsonNCCigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthmaAm J Respir Crit Care Med20031168111308131112893649
- TomlinsonJEMcMahonADChaudhuriRThompsonJMWoodSFThomsonNCEfficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthmaThorax200560428228715790982
- PolosaRKnokeJDRussoCCigarette smoking is associated with a greater risk of incident asthma in allergic rhinitisJ Allergy Clin Immunol200812161428143418436295
- CurrieGPJacksonCMLeeDKLipworthBJAllergen sensitization and bronchial hyper-responsiveness to adenosine monophosphate in asthmatic patientsClin Exp Allergy200333101405140814519147
- Le MoualNSirouxVPinIKauffmannFKennedySMAsthma severity and exposure to occupational asthmogensAm J Respir Crit Care Med2005172444044515961697
- SinDDSutherlandERObesity and the lung: 4. Obesity and asthmaThorax200863111018102318984817
- van VeenIHten BrinkeASterkPJRabeKFBelEHAirway inflammation in obese and nonobese patients with difficult-to-treat asthmaAllergy200863557057418394131
- CamargoCAJrWeissSTZhangSWillettWCSpeizerFEProspective study of body mass index, weight change, and risk of adult-onset asthma in womenArch Intern Med1999159212582258810573048
- HakalaKStenius-AarnialaBSovijarviAEffects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthmaChest200011851315132111083680
- Stenius-AarnialaBPoussaTKvarnstromJGronlundELYlikahriMMustajokiPImmediate and long term effects of weight reduction in obese people with asthma: randomised controlled studyBMJ2000320723882783210731173
- http://www.fp7-consulting.be/en/ubiopred/.2008
- WenzelSESchwartzLBLangmackELEvidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristicsAm J Respir Crit Care Med199916031001100810471631
- ItoKChungKFAdcockIMUpdate on glucocorticoid action and resistanceJ Allergy Clin Immunol2006117352254316522450
- RobertsNJRobinsonDSPartridgeMRHow is difficult asthma managed?Eur Respir J200628596897316807267
- NoonanMChervinskyPBusseWWFluticasone propionate reduces oral prednisone use while it improves asthma control and quality of lifeAm J Respir Crit Care Med19951525 Pt 1146714737582278
- GibsonPGPowellHDucharmeFLong-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and childrenCochrane Database Syst Rev20054CD00507616235393
- NightingaleJARogersDFBarnesPJComparison of the effects of salmeterol and formoterol in patients with severe asthmaChest20022151401140612006420
- GuyerBGibbsRFeldsienDWenzelSA pilot study to evaluate the bronchodilator response pattern to salmeterol in refractory asthmaJ Allergy Clin Immunol2002109S244
- TonelliMZingoniMBacciEShort-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmaticsPulm Pharmacol Ther200316423724012850127
- RodrigoGJRodrigoCTriple inhaled drug protocol for the treatment of acute severe asthmaChest200312361908191512796167
- VirchowJCLommatzchMAnticholinergic agents in asthmaOxfordClinical Publishing2007
- VatrellaAPonticielloAPelaiaGParrellaRCazzolaMBronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthmaPulm Pharmacol Ther2005182899215649850
- RobertsGNewsomDGomezKIntravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trialThorax200358430631012668792
- SilvermanRAOsbornHRungeJIV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trialChest2002122248949712171821
- BeasleyRAldingtonSMagnesium in the treatment of asthmaCurr Opin Allergy Clin Immunol20077110711017218820
- MortimerKJTattersfieldAEBenefit versus risk for oral, inhaled, and nasal glucocorticosteroidsImmunol Allergy Clin North Am200525352353916054541
- KeenanGFManagement of complications of glucocorticoid therapyClin Chest Med19971835075209329873
- JosephABrasingtonRKahlLRanganathanPChengTPAtkinsonJImmunologic rheumatic disordersJ Allergy Clin Immunol1252 Suppl 2S204S21520176259
- CometRDomingoCLarrosaMBenefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled studyRespir Med2006100341141916099632
- HedmanJSeidemanPAlbertioniFStenius-AarnialaBControlled trial of methotrexate in patients with severe chronic asthmaEur J Clin Pharmacol19964953473498866626
- TriggCJDaviesRJComparison of methotrexate 30 mg per week with placebo in chronic steroid-dependent asthma: a 12-week double-blind, cross-over studyRespir Med19938732112168497701
- MullarkeyMFLammertJKBlumensteinBALong-term methotrexate treatment in corticosteroid-dependent asthmaAnn Intern Med199011285775812327677
- ShinerRJKatzIShulimzonTSilkoffPBenzaraySMethotrexate in steroid-dependent asthma: long-term resultsAllergy19944975655687825725
- DomingoCMorenoAAmengualMJCometRLujanMTwelve years’ experience with methotrexate for GINA treatment step 5 asthma patientsCurr Med Res Opin200925236737419192981
- AaronSDDalesREPhamBManagement of steroid-dependent asthma with methotrexate: a meta-analysis of randomized clinical trialsRespir Med1998928105910659893776
- DaviesHOlsonLGibsonPMethotrexate as a steroid sparing agent for asthma in adultsCochrane Database Syst Rev20002CD00039110796540
- MarinMGLow-dose methotrexate spares steroid usage in steroid-dependent asthmatic patients: a meta-analysisChest1997112129339228353
- CorriganCJKayABT cells and eosinophils in the pathogenesis of asthmaImmunol Today199213125015071361126
- FukudaTAsakawaJMotojimaSMakinoSCyclosporine A reduces T lymphocyte activity and improves airway hyperresponsiveness in corticosteroid-dependent chronic severe asthmaAnn Allergy Asthma Immunol199575165727621064
- KhanLNKonOMMacfarlaneAJAttenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxinAm J Respir Crit Care Med20001624 Pt 11377138211029348
- SihraBSKonOMDurhamSRWalkerSBarnesNCKayABEffect of cyclosporin A on the allergen-induced late asthmatic reactionThorax19975254474529176537
- LockSHKayABBarnesNCDouble-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthmaAm J Respir Crit Care Med199615325095148564089
- NizankowskaESojaJPinisGTreatment of steroid-dependent bronchial asthma with cyclosporinEur Respir J199587109110997589392
- AlexanderAGBarnesNCKayABTrial of cyclosporin in corticosteroid-dependent chronic severe asthmaLancet19923987893243281346410
- NizankowskaEDworskiRSzczeklikACyclosporin for a severe case of aspirin-induced asthmaEur Respir J1991433801864356
- SzczeklikANizankowskaEDworskiRDomagalaBPinisGCyclosporin for steroid-dependent asthmaAllergy19914643123151897692
- EvansDJCullinanPGeddesDMCyclosporin as an oral corticosteroid sparing agent in stable asthmaCochrane Database Syst Rev20012CD00299311406057
- DougadosMAwadaHAmorBCyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patientsAnn Rheum Dis19884721271333281603
- KornbluthAPresentDHLichtigerSHanauerSCyclosporin for severe ulcerative colitis: a user’s guideAm J Gastroenterol1997929142414289317057
- SpectorSLKatzFHFarrRSTroleandromycin: effectiveness in steroid-dependent asthma and bronchitisJ Allergy Clin Immunol1974546367379
- SzeflerSJRoseJQEllisEFSpectorSLGreenAWJuskoWJThe effect of troleandomycin on methylprednisolone eliminationJ Allergy Clin Immunol19806664474516968763
- BlackPNBlasiFJenkinsCRTrial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniaeAm J Respir Crit Care Med2001164453654111520711
- JohnstonSLBlasiFBlackPNMartinRJFarrellDJNiemanRBThe effect of telithromycin in acute exacerbations of asthmaN Engl J Med2006354151589160016611950
- BallBDHillMRBrennerMSanksRSzeflerSJEffect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic childrenAnn Allergy199065137452195921
- KamadaAKHillMRIkleDNBrennerAMSzeflerSJEfficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthmaJ Allergy Clin Immunol19939148738828473676
- NelsonHSHamilosDLCorselloPRLevesqueNVBuchmeierADBucherBLA double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroidsAm Rev Respir Dis199314723984048430965
- GareyKWRubinsteinIGotfriedMHKhanIJVarmaSDanzigerLHLong-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthmaChest200011861826182711115481
- GotfriedMHJungRMessickCEffects of Six-Week Clarithromycin Therapy in Corticosteroid-Dependent Asthma: A Randomized Double-Blind, Placebo-Controlled Pilot StudyCurr Ther Res Clin Exp2004651112
- SimpsonJLPowellHBoyleMJScottRJGibsonPGClarithromycin targets neutrophilic airway inflammation in refractory asthmaAm J Respir Crit Care Med2008177214815517947611
- Omalizumab for persistent allergic asthmaExcellence NIoCLondonNICE technology appraisal guidance2007133
- GouldHJSuttonBJIgE in allergy and asthma todayNat Rev Immunol20088320521718301424
- PrestaLShieldsRO’ConnellLThe binding site on human immunoglobulin E for its high affinity receptorJ Biol Chem19942694226368263737929356
- ShieldsRLWhetherWRZioncheckKInhibition of allergic reactions with antibodies to IgEInt Arch Allergy Immunol19951071–33083127613156
- BouletLPChapmanKRCoteJInhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic responseAm J Respir Crit Care Med19971556183518409196083
- FahyJVFlemingHEWongHHThe effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjectsAm J Respir Crit Care Med19971556182818349196082
- WalkerSMonteilMPhelanKLassersonTJWaltersEHAnti-IgE for chronic asthma in adults and childrenCochrane Database Syst Rev20062CD00355916625585
- BousquetJCabreraPBerkmanNThe effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthmaAllergy200560330230815679714
- BousquetJWenzelSHolgateSLumryWFreemanPFoxHPredicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthmaChest200412541378138615078749
- ChippsBCorrenJFinnAHedgecockSFoxHBloggMOmalizumab significantly improves quality of life in patients with severe persistent asthmaJ Allergy Clin Immunol20051152S5S19
- FinnAGrossGvan BavelJOmalizumab improves asthma-related quality of life in patients with severe allergic asthmaJ Allergy Clin Immunol2003111227828412589345
- VignolaAMHumbertMBousquetJEfficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLARAllergy200459770971715180757
- CruzAALimaFSarinhoESafety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infectionClin Exp Allergy200737219720717250692
- CazzolaMPolosaRAnti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthmaCurr Opin Allergy Clin Immunol200661435016505611
- MorjariaJBBabuKSHolgateSTPolosaRTumour necrosis factor alpha as a therapeutic target in asthmaDrug Discov Today Ther Strateg200633309316
- FeldmannMMainiRfor Lasker Clinical Medical Research AwardTNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseasesNat Med200391245125014520364
- ErinEMLeakerBRNicholsonGCThe effects of a monoclonal antibody directed against tumour necrosis factor-{alpha} (TNF-{alpha}) in asthmaAm J Respir Crit Care Med2006
- RouhaniFNMeitinCAKalerMMiskinis-HilligossDStylianouMLevineSJEffect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammationRespir Med20059991175118216085220
- BerryMAHargadonBShelleyMEvidence of a role of tumor necrosis factor alpha in refractory asthmaN Engl J Med2006354769770816481637
- HowarthPHBabuKSArshadHSTumour Necrosis Factor (TNF {alpha}) as a novel therapeutic target in symptomatic corticosteroid-dependent asthmaThorax2005
- MorjariaJBChauhanAJBabuKSPolosaRDaviesDEHolgateSTThe role of a soluble TNF-A receptor fusion protein (Etanercept) in corticosteroid-refractory asthma: a double blind, randomised placebo-controlled trialThorax2008
- WenzelSEBarnesPJBleeckerERA randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthmaAm J Respir Crit Care Med2009179754955819136369
- BongartzTSuttonAJSweetingMJBuchanIMattesonELMontoriVAnti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsJAMA2006295192275228516705109
- DesaiDBrightlingCCytokine and anti-cytokine therapy in asthma: ready for the clinic?Clin Exp Immunol20091581101919737225
- LeckieMJten BrinkeAKhanJEffects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic responseLancet200035692482144214811191542
- Flood-PagePTMenzies-GowANKayABRobinsonDSEosinophil’s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airwayAm J Respir Crit Care Med2003167219920412406833
- Flood-PagePSwensonCFaifermanIA study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthmaAm J Respir Crit Care Med2007176111062107117872493
- KipsJCO’ConnorBJLangleySJEffect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot studyAm J Respir Crit Care Med2003167121655165912649124
- Flood-PagePMenzies-GowAPhippsSAnti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmaticsJ Clin Invest200311271029103614523040
- HaldarPBrightlingCEHargadonBMepolizumab and exacerbations of refractory eosinophilic asthmaN Engl J Med20093601097398419264686
- NairPPizzichiniMMKjarsgaardMMepolizumab for prednisone-dependent asthma with sputum eosinophiliaN Engl J Med20093601098599319264687
- AzzawiMJohnstonPWMajumdarSKayABJefferyPKT lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosisAm Rev Respir Dis19921456147714821596021
- ParkCSLeeSMChungSWUhSKimHTKimYHInterleukin-2 and soluble interleukin-2 receptor in bronchoalveolar lavage fluid from patients with bronchial asthmaChest199410624004067774310
- KonOMKayABAnti-T cell strategies in asthmaInflamm Res1999481051652310563467
- RobinsonDSBentleyAMHartnellAKayABDurhamSRActivated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsivenessThorax199348126328434349
- BusseWWIsraelENelsonHSDaclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trialAm J Respir Crit Care Med2008178101002100818787222
- WoodruffPGDolganovGMFerrandoREHyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expressionAm J Respir Crit Care Med200416991001100614726423
- CarrollNElliotJMortonAJamesAThe structure of large and small airways in nonfatal and fatal asthmaAm Rev Respir Dis199314724054108430966
- DanekCJLombardCMDungworthDLReduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogsJ Appl Physiol20049751946195315258133
- MillerJDCoxGVincicLLombardCMLoomasBEDanekCJA prospective feasibility study of bronchial thermoplasty in the human airwayChest200512761999200615947312
- CoxGMillerJDMcWilliamsAFitzgeraldJMLamSBronchial thermoplasty for asthmaAm J Respir Crit Care Med2006173996596916456145
- CoxGThomsonNCRubinASAsthma control during the year after bronchial thermoplastyN Engl J Med2007356131327133717392302
- PavordIDCoxGThomsonNCSafety and efficacy of bronchial thermoplasty in symptomatic, severe asthmaAm J Respir Crit Care Med2007176121185119117901415
- CastroMRubinASLavioletteMEffectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trialAm J Respir Crit Care Med181211612419815809